logo

Select Sidearea

Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.
hello@youremail.com
+1234567890

Industry News

Thanks to everyone who stopped by the EDITLife booth at the TCT 2019 Meetings in Houston! We were thrilled to connect with so many industry leaders and with the positive response to EDITLife for Cell Therapy - the patient-centric, transplant management software system that efficiently tracks and monitors BMT-specific data and supplements your EHR. And, we were inspired to work even harder to ensure that...

Read More

See EDITLife at UNOS 2019! MSA is happy to announce that we will be attending the 27th annual UNOS Transplant Management Forum (TMF) 2019, May 13-14, Loews Sapphire Falls Resort in Orlando.   Plan now to stop by Booth #35.  Meet up with our team of experts: Tony Fontecchio, VP, Life Sciences, and Ed Smith, Director, Business Development. See for yourself how EDITLife, a comprehensive, patient-centric, transplant...

Read More

MSA Life Sciences, developers of the EDITLife Transplant Management System (TMS) for Cell Therapy, is pleased to be supporting the 2019 Transplantation and Cellular Therapy (TCT) Meetings. Team leaders will exhibit the state-of-the-art EDITLife clinical workflow application, February 19-23, at the Hilton Americas in Houston, TX.   Something new and exciting this year: the EDITLife team will be hosting helpful educational sessions every day in Booth #2246....

Read More

Thanks to everyone who stopped by the EDITLife booth at NMDP Council Meeting 2018! The conference was a huge success again this year.  We were thrilled to connect with so many industry leaders and overwhelmed by the positive response to EDITLife - the transplant management system (TMS) that streamlines the BMT process! Congratulations to the following lucky raffle winners of the Google Home Minis: Lisa Tyrrell,...

Read More

Findings presented at the American Society of Nephrology's Kidney Week 2018 suggest that gout, a risk factor for serious poor health outcomes, is much more common among solid organ transplant recipients than in the general U.S. population. Using 2016 claims data, researchers found that the prevalence of active gout was 11.3% among solid organ transplant recipients - particularly kidney and heart transplant recipients -  compared...

Read More

MSA Life Sciences, developers of the EDITLife Transplant Management System (TMS), is pleased to be sponsoring the NMDP (National Marrow Donor Program) Council Meeting 2018 for the 3rd consecutive year. Division reps will demonstrate the state-of-the-art, EDITLife clinical workflow application at the event, which takes place November 9-10, at the Hilton in Minneapolis, MN.   Bringing together the professionals who work every day to ensure the best...

Read More

Pittsburgh, PA; September 21, 2018 – Today MSA and Extract Systems announced a business partnership that provides MSA’s EDITLife Transplant Management System (TMS) users the ability to access patient data captured in unstructured documents utilizing Extract’s data extraction tools. Currently, administrative and clinical staff at many Blood and Marrow (BMT) and Solid Organ transplant centers manually enter lab values and other critical patient information into reports,...

Read More

Penn Medicine launched an innovative clinical trial in 2016 to test the effect of transplanting kidneys from donors with Hepatitis C virus (HCV) into patients currently on the kidney waitlist who do not have the virus and would opt in to receive these otherwise unused organs. After transplantation, recipients were treated with an antiviral therapy in an effort to cure the virus. To date, 20 patients have...

Read More

Nearly 2,000 children under 18 years old are on the U.S. organ transplant waiting list. Of those, approximately 500 are children ages 1 to 5. In order to raise awareness of the need for organ donors, several transplant organizations - including Transplant Families - is introducing the first annual National Pediatric Transplant Week, April 23-27. As part of National Donate Life Month, this week gives...

Read More

A novel imaging test using the imaging agent 18F-fluorothymidine (18FLT) identifies success of HSCT engraftment weeks before a traditional blood test. This imaging technique — a less painful option than bone marrow biopsies — also allowed researchers to better understand the engraftment process following HSCT. A study led by blood and marrow transplant specialists at Children's National Health System suggest that 18FLT could be useful to assess subclinical...

Read More